AHCO Logo

AdaptHealth Corp. (AHCO) 

NASDAQ
Market Cap
$1.38B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
517 of 960
Rank in Industry
63 of 120

Largest Insider Buys in Sector

AHCO Stock Price History Chart

AHCO Stock Performance

About AdaptHealth Corp.

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic …

Insider Activity of AdaptHealth Corp.

Over the last 12 months, insiders at AdaptHealth Corp. have bought $0 and sold $6M worth of AdaptHealth Corp. stock.

On average, over the past 5 years, insiders at AdaptHealth Corp. have bought $4.19M and sold $45.12M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 720 shares for transaction amount of $10,152 was made by Clemens Jason A (Chief Financial Officer) on 2023‑08‑10.

List of Insider Buy and Sell Transactions, AdaptHealth Corp.

2024-12-10SaleChief Financial Officer
35,000
0.0259%
$9.35$327,250+3.30%
2024-11-13Saledirector
7,000
0.0053%
$10.80$75,600-8.21%
2024-09-20SaleFormer Chief Operating Officer
25,000
0.0186%
$11.24$281,000-9.91%
2024-08-29Saledirector
4,000
0.003%
$11.26$45,040-6.50%
2024-05-24Saledirector
1,409
0.0011%
$9.97$14,048+4.52%
2024-05-23Saledirector
3,100
0.0024%
$9.90$30,690+9.15%
2024-03-12Sale*Possible Member of 10% Group
114,906
0.0832%
$10.70$1.23M-5.08%
2024-03-11Sale*Possible Member of 10% Group
182,607
0.1361%
$11.02$2.01M-5.25%
2024-03-08Sale*Possible Member of 10% Group
52,487
0.0387%
$10.93$573,652-5.21%
2024-03-04SaleChief Technology Officer
135,443
0.0978%
$10.41$1.41M-2.36%
2023-12-04Saledirector
2,255
0.0017%
$9.30$20,972+9.13%
2023-08-11Saledirector
196,839
0.148%
$14.02$2.76M-31.92%
2023-08-10Saledirector
128,788
0.0963%
$14.05$1.81M-32.36%
2023-08-10SaleChief Technology Officer
200,000
0.151%
$14.18$2.84M-32.36%
2023-08-10PurchaseChief Financial Officer
720
0.0005%
$14.10$10,152-32.36%
2023-02-06Sale
540,000
0.4146%
$20.75$11.21M-47.00%
2023-02-01Sale
44,789
0.0328%
$21.00$940,569-49.23%
2023-01-31Sale
55,211
0.0403%
$21.00$1.16M-48.97%
2023-01-18Saledirector
4,789
0.0037%
$22.00$105,358-47.88%
2023-01-13Saledirector
10,201
0.0074%
$21.00$214,221-47.97%

Insider Historical Profitability

19.39%
Clemens Jason AChief Financial Officer
420719
0.3127%
$10.2831+15.91%
WOLF DALE Bdirector
74889
0.0557%
$10.2841+33.69%
GRIGGS STEPHEN PChief Executive Officer
3576927
2.6583%
$10.2830+7.28%
SkyKnight Capital Fund II, L.P.director
2684543
1.9951%
$10.2860+25%
Ebbel Matthew
200000
0.1486%
$10.28100+17.68%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
One Equity Partners$159.05M10.3713.82M0%+$057.85
BlackRock$157.05M10.2413.64M-3%-$4.86M<0.01
Deerfield Management$152.6M9.9513.26M-2.57%-$4.03M0.37
The Vanguard Group$115.3M7.5210.02M+8.89%+$9.42M<0.01
SkyKnight Capital$98.76M6.448.58M0%+$093.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.